These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 18772488)

  • 1. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance.
    Traish AM; Saad F; Guay A
    J Androl; 2009; 30(1):23-32. PubMed ID: 18772488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.
    Traish AM; Guay A; Feeley R; Saad F
    J Androl; 2009; 30(1):10-22. PubMed ID: 18641413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dark side of testosterone deficiency: III. Cardiovascular disease.
    Traish AM; Saad F; Feeley RJ; Guay A
    J Androl; 2009; 30(5):477-94. PubMed ID: 19342698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction.
    Guay AT; Traish A
    Urol Clin North Am; 2011 May; 38(2):175-83. PubMed ID: 21621084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency.
    Boyanov MA; Boneva Z; Christov VG
    Aging Male; 2003 Mar; 6(1):1-7. PubMed ID: 12809074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases.
    Corona G; Mannucci E; Forti G; Maggi M
    Int J Androl; 2009 Dec; 32(6):587-98. PubMed ID: 19226407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging link between hypogonadism and metabolic syndrome.
    Guay AT
    J Androl; 2009; 30(4):370-6. PubMed ID: 18772486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgens, insulin resistance and vascular disease in men.
    Kapoor D; Malkin CJ; Channer KS; Jones TH
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):239-50. PubMed ID: 16117808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of androgen deficiency in men with erectile dysfunction.
    Köhler TS; Kim J; Feia K; Bodie J; Johnson N; Makhlouf A; Monga M
    Urology; 2008 Apr; 71(4):693-7. PubMed ID: 18313109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone deficiency and the metabolic syndrome.
    Lunenfeld B
    Aging Male; 2007 Jun; 10(2):53-6. PubMed ID: 17558968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes?
    Corona G; Mannucci E; Forti G; Maggi M
    Int J Androl; 2009 Oct; 32(5):431-41. PubMed ID: 19538523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone and type 2 diabetes.
    Grossmann M; Gianatti EJ; Zajac JD
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):247-56. PubMed ID: 20418720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome.
    Corona G; Forti G; Maggi M
    Aging Male; 2008 Dec; 11(4):193-9. PubMed ID: 19172551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction.
    Traish AM; Feeley RJ; Guay A
    FEBS J; 2009 Oct; 276(20):5755-67. PubMed ID: 19754871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Androgen deficit and diabetes].
    Cáp J
    Vnitr Lek; 2012 Mar; 58(3):228-31. PubMed ID: 22486290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen pattern in patients with type 2 diabetes-associated erectile dysfunction: impact of metabolic control.
    El-Sakka AI; Sayed HM; Tayeb KA
    Urology; 2009 Sep; 74(3):552-9. PubMed ID: 19592073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and cardiovascular diseases].
    Kalinchenko SIu; Vorslov LO; Aglamazian NL; Morgunov LIu
    Urologiia; 2007; (1):57, 59-61. PubMed ID: 17472002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic rate and vascular function are reduced in women with a family history of type 2 diabetes mellitus.
    Olive JL; Ballard KD; Miller JJ; Milliner BA
    Metabolism; 2008 Jun; 57(6):831-7. PubMed ID: 18502267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction.
    El-Sakka AI; Sayed HM; Tayeb KA
    Int J Androl; 2008 Dec; 31(6):602-8. PubMed ID: 17877718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypogonadism and metabolic syndrome: implications for testosterone therapy.
    Makhsida N; Shah J; Yan G; Fisch H; Shabsigh R
    J Urol; 2005 Sep; 174(3):827-34. PubMed ID: 16093964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.